For women with bipolar disorder, choosing whether to maintain or discontinue treatment with a mood stabilizer during pregnancy is challenging. This is a process which requires careful and thoughtful consideration, weighing the risk of adverse [...]
May 1, 2019 from ObGynNews Publish date: May 1, 2019 By Lee S. Cohen, MD Careful management of bipolar disorder during pregnancy is critical because for so many patients with this illness, the road to emotional [...]
EURAP is an international registry for antiepileptic drugs and pregnancy. At its inception in 1999, it included only European countries but EURAP has grown and now includes 42 countries from Europe, Australia, Asia, South America. [...]
Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly used in this setting, including lithium and [...]
January was Birth Defects Prevention Month, and MotherToBaby launched a free app designed to provide evidence-based information to pregnant and breastfeeding women. There is Information on a broad range of medications, some herbal remedies, [...]
Many of the newer antiepileptic drugs (AEDs) have uses beyond the treatment of epilepsy. Topiramate (marketed as a Topamax), in addition to its use for the treatment of epilepsy, is now being prescribed to reproductive [...]